An observational study assessing Tau-load in the lingual gyrus impacts anxiety levels during the COVID-19 pandemic
Latest Information Update: 13 Sep 2021
At a glance
- Drugs Florquinitau F18 (Primary)
- Indications Alzheimer's disease; Neurodegenerative disorders
- Focus Diagnostic use
- 13 Sep 2021 New trial record
- 30 Jul 2021 Results presented at the Alzheimer's Association International Conference 2021